Pharmacy Guild executive
director David Quilty says the
recommendations of the Harper
Review into competition, which
suggested opening up pharmacy to
supermarkets, are “deeply flawed
and bereft of evidence”.
He said the review did not
produce any serious empirical
evidence that such a change would
produce any net benefit to patients.
In contrast the Guild’s submission
to the Harper Review Panel showed
a social and economic loss of over
$700m a year would result from the
deregulation of pharmacy, with the
Guild vowing to continue to defend
the current model.The above article was sent to subscribers in Pharmacy Daily's issue from 26 Nov 15 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 26 Nov 15
BREAST Cancer Network Australia (BCNA) has welcomed a PBAC recommendation to subsidise the breast cancer drug Enhertu (trastuzumab deruxtecan) for HER2-low metastatic breast cancer on the PBS.
PHARMACY Connect (PC2024) has revealed that Olympian Peter Bol will be sharing his journey from adversity to athletic greatness at the conference in Sep in Sydney.
IN WESTERN Australia, Michael’s Chemist Group has started stocking therapeutic Nicotine Vaping Products (NVPs), pursuant to the Federal Government’s new vaping laws (PD 25 Mar).
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.